If You Invested in Viveon Health Acq CRP (VHAQ)
See the VHAQ overviewWhat $1,000 or $10,000 in VHAQ Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since Feb 4, 2021 |
|---|---|---|---|---|
| $1,000 | $884 -12% | — | — | $980 -2% |
| $10,000 | $8,842 -12% | — | — | $9,804 -2% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2024-09-05. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for VHAQ$1,000 Investment Over Time
VHAQ vs S&P 500Year-by-Year Returns
VHAQ annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2021Feb 4, 2021 to Dec 31, 2021 | $10.20 | $10.02 | -1.8% | -1.8% |
| 2022 | $10.02 | $10.65 | +6.3% | +4.4% |
| 2023 | $10.65 | $11.28 | +5.9% | +10.6% |
| 2024Dec 29, 2023 to Sep 5, 2024 | $11.28 | $10.00 | -11.3% | -2.0% |
About Viveon Health Acq CRP
OTC
Frequently Asked Questions
Viveon Health Acq CRP investment returns
How much was $1,000 invested in Viveon Health Acq CRP worth at its last close?
If you invested $1,000 in Viveon Health Acq CRP (VHAQ) 1 year before its last close, on 2023-09-05, your investment was worth $884 on 2024-09-05, a -11.6% price return without dividends, growing at a compounded rate of -11.6% per year (CAGR).
Has Viveon Health Acq CRP outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare VHAQ performance over available time periods.
What is Viveon Health Acq CRP's average annual return?
The compound annual growth rate (CAGR) of VHAQ’s share price over the 1 year to Sep 5, 2024 is -11.6%, without dividends. Individual years vary a great deal, and VHAQ’s best recent full year was 2022 (+6.3%) while the worst was 2023 (+5.9%).
For informational and educational purposes only, not investment advice.
